What We Do
Strategy & Commercialization
Strategy & Commercialization
Strategy & Commercialization
We assist you in developing your pitch deck, business plans, go-to-market commercialization and launch plans, growth initiatives as well as business and market entry strategies.
Specific Areas:
Business Plans | Pitch Deck | Strategic Marketing | Commercialization | Market Development | Clinical Marketing | Global Product Launch
Product Innovation
Strategy & Commercialization
Strategy & Commercialization
We assist you in developing innovative products that address customer unmet needs, drive differentiation and deliver business results.
Specific Areas:
New Product Development | Product & Solution Definition | Feasibility & Clinical Research | Clinical, Economic & Marketing Claims | Clinical & Regulatory Strategy | Intellectual Property
Clients
Informed strategic decision to enter a new market by delivering an analysis of total product development cost and time to market for a new implantable medical device.
Guided go-to-market and commercialization strategy by delivering a marketing plan inclusive of product roadmap, pricing strategy, clinical and economic claims matrix, financial and economic models for their flagship AR technology.
Delivered market opportunity assessment for an indication expansion of their core venous closure device into an adjacent market.
Researched and authored a secondary market research report on the state of affairs of federal and state subsidized drug discount programs.
Delivered an economic model that computes payer savings associated with the use of an implantable blood pressure monitor in a high risk patient population.
Experience
Founder has over 16 years experience in the medical device industry and specifically in cardiac rhythm management, vascular surgery and electrophysiology.
Launched next generation high voltage defibrillation leads for implantable cardioverter defibrillators accounting for $295MM in annual revenue for the business.
Commercialized traditional and polymer based endografts for the treatment of abdominal aortic aneurysms resulting in $192 MM in revenue in 2016.
Led the strategy and product pipeline definition for a variety of product categories in the cardiovascular space including noninvasive cardiac mapping, endografts for AAA repair, and a novel implantable cardioverter defibrillator platform.
Developed business strategies for new product categories for sleep apnea, electrophysiology mapping and navigation, and implantable defibrillators.
Designed, developed and implemented pre-clinical and clinical research studies to evaluate new pacing, sensing and detection algorithms for implantable devices.
Co-invented over 32 patents in the fields of cardiac electrophysiology and cardiac rhythm management.
Co-authored several abstracts and scientific manuscripts in peer-reviewed journals.
Learn more... go to About
